Relafen or Naproxen 750, viewed or considered from a biochemical pharmaceutical pharmacy perspective, represents a compelling significant illustration of NSAID pain reliever action. Its mechanism or mode involves primarily substantially inhibiting cyclooxygenase prostaglandin synthetase , specifically COX-2, thereby reducing diminishing the product